Skip to main content
Fig. 4 | BMC Pharmacology and Toxicology

Fig. 4

From: Dapagliflozin attenuates metabolic dysfunction-associated steatotic liver disease by inhibiting lipid accumulation, inflammation and liver fibrosis

Fig. 4

DaPa improves liver fibrosis in DIO mice. (A, B) Sirus Red staining (A) and Masson’s Trichrome staining (B) in liver tissues from CON, DIO, and DIO + DaPa groups (scale bar, 100 μm). (C, D, E) Immunohistochemical staining of liver tissues for α-SMA (C), collagen I (D), and fibronectin (E) (scale bar, 100 μm). Data are presented as mean ± SD (n = 6)

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us